June 13, 2022/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Haematology Market.
It was estimated prior to this unanticipated outbreak that the Haematology Market is likely to witness an impressive CAGR of 5.5% during the forecast period. Growing incidences of blood disorders and other diseases, increasing importance of hematological testing in COVID-19 infected patients, rapid technological advancements in hematology, and the emergence of high throughput hematology analyzers are some of the major factors expected to drive the growth of the market during the forecast period.
Market Scope & Segmentation
Hematology is a branch of medical science which dealas with the cause, treatment, prognosis, and prevention of diseases related to blood and blood-forming organs.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market
For a more detailed breakdown of the COVID-19 impact on the Haematology Market, request a free sample of the report here:
https://www.stratviewresearch.com/Request-Sample/416/clinical-haematology-market.html#form
Segments' Analysis
Based on the product type, the market is segmented as hematology analyzers, flow cytometers, coagulation analyzers, slide stainers, centrifuges, hemoglobinometers, and others. The market for hematology analyzers is expected to register promising gains during the projected period, owing to the rising prevalence of blood-related disorders, which is driving the demand for hematology tests and their technological advancements.
In terms of regions, North America is estimated to account for the major share of the market during the forecast period, owing to the rising incidences of blood-related disorders and diseases, technological advancements, and an increase in the number of product launches in the region. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Key Players:
Key players operating in the global Clinical Haematology market are-
- Abbott Laboratorie
- Agilent Technologies Inc
- Bio-Rad Laboratories Inc
- Danaher Corporatio
- Diatron MI PL
- Drew Scientific Grou
- F. Hoffmann-La Roche A
- Fluidigm Corporatio
- Novo Nordisk A/
- PerkinElmer Inc.
Features of the Report
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
The Clinical Haematology analysis report discusses the following heads in great detail:
- Market structure: Overview, industry life cycle analysis, supply chain analysis
- COVID-19 Impact Assessment
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
- Market trend and forecast analysis
- Market segment trend and forecast
- Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
- Attractive market segments and associated growth opportunities
- Emerging trends
- Strategic growth opportunities for the existing and new players
- Key success factors
Know more about Stratview Research:
Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.
Need a detailed report? Get in touch with us:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176
